Human Longevity Inc. [2013] a pioneer and leader in precision health
and parent company to Health NucleusTM and Longevity and Performance
Impact Venture Fund (LPIF), has become a clearing house for promising
longevity and performance focused technologies. With the longevity
economy expected to reach twenty six (26) trillion dollars by 2017 LPIF
is seeking to raise $50M to establish synergistic ecosystem of
high-impact translational research, diagnostic and therapeutic
companies.
Contact us for investor relations information